A prospective, randomized controlled trial comparing the efficacy of recombinant follicle-stimulating hormone in three different in vitro fertilization protocols
A. Ravhon et al., A prospective, randomized controlled trial comparing the efficacy of recombinant follicle-stimulating hormone in three different in vitro fertilization protocols, FERT STERIL, 73(5), 2000, pp. 908-912
Objective: To compare the following IVF protocols: a short protocol and lon
g protocols starting on day 2 or day 21. All protocols used recombinant FSH
(rFSH) for ovarian stimulation.
Design: Prospective, randomized study.
Setting: An assisted reproduction unit at a university center.
Patient(s): Patients undergoing IVF (n = 150) were treated according to one
of the three treatment protocols allocated by a random method.
Intervention(s): All patients used buserelin acetate and rFSH. Patients beg
an the long protocol on day 2 (group 1) or day 21 (group 2) of the cycle. P
atients in group 3 began the short protocol on day 2 of the cycle.
Main Outcome Measure(s): Ovarian response, implantation rates, and pregnanc
y rates (PRs).
Result(s): Patients treated with the short protocol (group 3) were stimulat
ed in a shorter time, required less rFSH, and achieved higher E-2 levels. T
he numbers of follicles, oocytes, and embryos were similar in all three gro
ups. The implantation rates were similar in groups 1 and 2 (11.8% and 13.3%
, respectively), and both were higher than in group 3 (4.1%). Clinical PRs
per oocytes retrieved were 19.6%, 18.6% and 8.3% in groups 1, 2, and 3, res
pectively.
Conclusion(s): The implantation rate was significantly higher with the long
protocols than with the short protocol, with a tendency for a higher PR as
well. (Fertil Steril(R) 2000;73:908 -12. (C) 2000 by American Society for
Reproductive Medicine).